JP2025509955A5 - - Google Patents
Info
- Publication number
- JP2025509955A5 JP2025509955A5 JP2024556125A JP2024556125A JP2025509955A5 JP 2025509955 A5 JP2025509955 A5 JP 2025509955A5 JP 2024556125 A JP2024556125 A JP 2024556125A JP 2024556125 A JP2024556125 A JP 2024556125A JP 2025509955 A5 JP2025509955 A5 JP 2025509955A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- aqueous pharmaceutical
- pharmaceutical composition
- hydrocortisone
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263321997P | 2022-03-21 | 2022-03-21 | |
| US63/321,997 | 2022-03-21 | ||
| US202263322934P | 2022-03-23 | 2022-03-23 | |
| US63/322,934 | 2022-03-23 | ||
| US202263387727P | 2022-12-16 | 2022-12-16 | |
| US63/387,727 | 2022-12-16 | ||
| PCT/US2023/064771 WO2023183807A1 (en) | 2022-03-21 | 2023-03-21 | Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509955A JP2025509955A (ja) | 2025-04-11 |
| JP2025509955A5 true JP2025509955A5 (enExample) | 2026-03-31 |
Family
ID=88102190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556125A Pending JP2025509955A (ja) | 2022-03-21 | 2023-03-21 | リン酸ヒドロコルチゾンナトリウム及びモノチオグリセロール水性医薬製剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US12102643B2 (enExample) |
| EP (1) | EP4496575A4 (enExample) |
| JP (1) | JP2025509955A (enExample) |
| CA (1) | CA3246335A1 (enExample) |
| WO (1) | WO2023183807A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023183807A1 (en) * | 2022-03-21 | 2023-09-28 | Antares Pharma, Inc. | Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2970944A (en) | 1958-04-04 | 1961-02-07 | Merck & Co Inc | Parenteral solutions of steroid phosphates stabilized with creatinines |
| IL34366A (en) * | 1969-05-07 | 1973-06-29 | Lepetit Spa | Stable aqueous 21-hydroxy steroid phosphate solutions |
| US5173488A (en) * | 1989-08-21 | 1992-12-22 | American Cyanamid Company | Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method |
| US5733572A (en) | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| US6090800A (en) | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
| US20020039594A1 (en) | 1997-05-13 | 2002-04-04 | Evan C. Unger | Solid porous matrices and methods of making and using the same |
| WO2006079064A1 (en) | 2005-01-24 | 2006-07-27 | Antares Pharma, Inc. | Prefilled needle assisted jet injector |
| ZA200804550B (en) | 2005-11-09 | 2009-08-26 | Combinatorx Inc | Methods, compositions, and kits for the treatment of medical conditions |
| JP5731829B2 (ja) | 2008-03-10 | 2015-06-10 | アンタレス・ファーマ・インコーポレーテッド | 注射器安全装置 |
| AU2010226442A1 (en) | 2009-03-20 | 2011-10-13 | Antares Pharma, Inc. | Hazardous agent injection system |
| WO2014165142A1 (en) | 2013-03-13 | 2014-10-09 | Benjamin Newton | Multiple dosage injector with rotating screw dosage system |
| ES2673290T3 (es) * | 2016-01-11 | 2018-06-21 | Lamda Laboratories S.A. | Soluciones farmacéuticas orales que contienen fosfato sódico de hidrocortisona |
| FR3047904B1 (fr) | 2016-02-18 | 2018-03-23 | Crossject | Dispositif d’injection sans aiguille a membrane coulissante |
| FR3057775B1 (fr) * | 2016-10-26 | 2018-11-02 | Crossject | Solution pharmaceutique d’hydrocortisone pour dispositif d’injection |
| US11814341B2 (en) | 2018-05-04 | 2023-11-14 | Ohio State Innovation Foundation | Non-peptidic cell-penetrating motifs |
| JP2022511029A (ja) | 2018-12-04 | 2022-01-28 | スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド | がんの処置のための薬剤としての使用のためのｃｄｋ９インヒビターおよびその多形 |
| AU2021345429A1 (en) * | 2020-09-21 | 2023-05-04 | Antares Pharma, Inc. | Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol |
| FR3128874B1 (fr) * | 2021-11-09 | 2025-04-18 | Crossject | Solution pharmaceutique d’hydrocortisone pour dispositif d’injection |
| WO2023183807A1 (en) * | 2022-03-21 | 2023-09-28 | Antares Pharma, Inc. | Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol |
-
2023
- 2023-03-21 WO PCT/US2023/064771 patent/WO2023183807A1/en not_active Ceased
- 2023-03-21 EP EP23775847.9A patent/EP4496575A4/en active Pending
- 2023-03-21 CA CA3246335A patent/CA3246335A1/en active Pending
- 2023-03-21 JP JP2024556125A patent/JP2025509955A/ja active Pending
- 2023-03-24 US US18/189,613 patent/US12102643B2/en active Active
-
2024
- 2024-03-20 US US18/611,251 patent/US12521404B2/en active Active
-
2025
- 2025-12-09 US US19/413,640 patent/US20260091042A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rasmussen et al. | Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis | |
| JP2023109938A (ja) | 抗体製剤 | |
| US6911475B1 (en) | Use of nicotine or its derivatives in a drug for treating neurological disease, in particular Parkinson's disease | |
| JP2023542345A5 (enExample) | ||
| CN105228622B (zh) | 用于治疗多发性硬化的PPARγ激动剂 | |
| JP2023551877A5 (enExample) | ||
| AU2014249530B2 (en) | Use of levocetirizine and montelukast in the treatment of anaphylaxis | |
| KR20200062241A (ko) | 시포니모드의 투여 요법 | |
| Walia et al. | Montelukast in pediatric asthma management | |
| US20190134023A1 (en) | Method of Restoring the Incretin Effect | |
| RU2023109329A (ru) | Водный фармацевтический состав на основе гидрокортизона натрия фосфата и монотиоглицерина | |
| US20240424000A1 (en) | Long-acting intra-articular dosage forms containing fluticasone propionate and use thereof | |
| JPS631295B2 (enExample) | ||
| WO2005063253A1 (ja) | アレルギー症状治療用医薬組成物 | |
| Romanova et al. | The dynamics of lung histopathology in acute baclofen poisoning | |
| CN110538183B (zh) | 一种预防和治疗小儿湿疹的组合物及其制备方法 | |
| Biradar et al. | Bullous pemphigoid a rare autoimmune disease: a case report | |
| US20190038624A1 (en) | Use of abelson tyrosine kinase inhibitor in treatment of multiple system atrophy | |
| TW202539621A (zh) | 用於治療巴金森氏症的治療劑 | |
| WO2025167710A1 (zh) | 三稠环化合物在制备预防和/或治疗炎性疾病药物中的应用 | |
| Bell | of study | |
| Garbe | The Action of Thenalidine Tartrate (Sandostene®) in Atopic Dermatitis: Evaluation of a new Anti-Allergic Preparation for Control of Pruritus and Treatment of Various Allergic Dermatoses | |
| CN111939164A (zh) | 奈立膦酸或其盐用于治疗骨关节炎的用途 | |
| WO2022089544A1 (zh) | Bzp在治疗心脑缺血性疾病中的应用 | |
| CN119970634A (zh) | 一种用于抑制炎症的醋酸甲泼尼龙注射液及其制备方法 |